
Bio-Techne Corp.
TECH
TECH: Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
moreShow TECH Financials
Recent trades of TECH by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TECH's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
- $17,611 2023-08-28 00:00:00 Agency: Department of Health and Human Services
- $19,383 2023-08-16 00:00:00 Agency: Department of Health and Human Services
- $11,685 2023-07-18 00:00:00 Agency: Department of Health and Human Services
- $14,400 2023-07-18 00:00:00 Agency: Department of Health and Human Services
- $24,395 2023-06-15 00:00:00 Agency: Department of Health and Human Services
- $19,972 2023-06-08 00:00:00 Agency: Department of Health and Human Services
- $23,900 2023-05-09 00:00:00 Agency: Department of Health and Human Services
Followers on TECH's company Twitter account
Number of mentions of TECH in WallStreetBets Daily Discussion
Recent insights relating to TECH
Recent picks made for TECH stock on CNBC
ETFs with the largest estimated holdings in TECH
Flights by private jets registered to TECH